Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Kenvue Inc. before investing.

In this article, we go over a few key elements for understanding Kenvue Inc.’s stock price such as:

• Kenvue Inc.’s current stock price and volume
• Why Kenvue Inc.’s stock price changed recently
• Upgrades and downgrades for KVUE from analysts
• KVUE’s stock price momentum as measured by its relative strength

About Kenvue Inc. (KVUE)

Before we jump into Kenvue Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women’s health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements. It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee’s Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson’s, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson’s Baby, Johnson’s Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.

Want to learn more about Kenvue Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Kenvue Inc..

Kenvue Inc.’s Stock Price as of Market Close

As of July 31, 2026, 4:00 PM, CST, Kenvue Inc.’s stock price was $19.240.

Kenvue Inc. is down 0.36% from its previous closing price of $19.310.

During the last market session, Kenvue Inc.’s stock traded between $18.950 and $19.340. Currently, there are approximately 1,918.00 million shares outstanding for Kenvue Inc..

Kenvue Inc.’s price-earnings (P/E) ratio is currently at 22.9, which is high compared to the Personal Care Products industry median of 16.4. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

Kenvue Inc. Stock Price History

Kenvue Inc.’s (KVUE) price is currently up 0.68% so far this month.

During the month of July, Kenvue Inc.’s stock price has reached a high of $20.130 and a low of $18.580.

Over the last year, Kenvue Inc. has hit prices as high as $22.285 and as low as $14.020. Year to date, Kenvue Inc.’s stock is up 11.54%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Kenvue Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of July 31, 2026, there was 1 analyst who downgraded Kenvue Inc.’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Kenvue Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Kenvue Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Kenvue Inc.’s current valuation based on AAII’s Value Grade is a D, which means it is considered to be Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Kenvue Inc. (KVUE) by visiting AAII Stock Evaluator.

Relative Price Strength of Kenvue Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of July 31, 2026, Kenvue Inc. has a weighted four-quarter relative price strength of -1.72%, which translates to a Momentum Score of 47 and is considered to be Average.

Want to learn more about how Kenvue Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Kenvue Inc. Stock Price: Bottom Line

As of July 31, 2026, Kenvue Inc.’s stock price is $19.240, which is down 0.36% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Kenvue Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.